Carregant...
Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia
OBJECTIVE: To evaluate efficacy and safety of ramelteon (MT(1)/MT(2)-receptor agonist) in subjects with chronic primary insomnia. METHODS: Randomized, multicenter, double-blind, placebo-controlled trial of nightly ramelteon treatment (8 mg or 16 mg) in adults (N=405) with primary chronic insomnia (D...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Academy of Sleep Medicine
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1978328/ https://ncbi.nlm.nih.gov/pubmed/17803013 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|